sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device North American Neuromodulation Market...

North American Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology [External (Non-Invasive) Neuromodulation and Internal Neuromodulation], Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine), and End User (Hospitals, Clinics, and Home Healthcare) and Country

TIPRE00016293 | Pages: 108 | Medical Device | Nov 2020 | Type: Regional | Status: Published

Market Introduction

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.


Get more information on this report :



Market Overview and Dynamics

The North America Neuromodulationmarketis projectedto reach US$ 6,612.00 millionby 2027 from US$ 3,029.72million in 2019; it is estimated to grow with a CAGR of 10.6% from 2020 to 2027.The growth of the North America neuromodulationmarket is attributed to the increasing incidence of neurological disorders, growing developments in neuromodulation technology. However, high cost of neuromodulation devicesthe growth of market in this region. leading to restraining the growth of the market.

Key Market Segments

Based on technology, the North America neuromodulationmarket is segmented into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulationsegment held a larger share of the market. External (non-invasive) neuromodulationis expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred towhile preparing the North Americaneuromodulationmarketreport are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim.

 

Reasons to buy the report

  • To understand the North America neuromodulationmarketlandscape and identifymarket segments that are most likely to guarantee a strong return
  • To stay ahead incomprehending the ever-changing competitive landscape of theNorth Americaneuromodulationmarket
  • To efficiently plan M&A and partnership dealsin the North Americaneuromodulationmarketby identifying market segments with the most promising probable sales
  • To help takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segmentsinthe North Americaneuromodulationmarket
  • To obtain market revenue forecast from 2019 to 2027 in various segmentsofthe North Americaneuromodulationmarket

NORTH AMRICA NEUROMODULATION MARKETSEGMENTATION

By Technology

·         External (Non-Invasive) Neuromodulation

o    Respiratory Electrical Stimulation

o    Transcutaneous Electrical Nerve Stimulation

o    Transcranial Magnetic Stimulation

·         Internal Neuromodulation

o    Deep Brain Stimulation

o    Sacral Nerve Stimulation

o    Gastric Electrical Stimulation

o    Spinal Cord Stimulation

o    Vagus Nerve Stimulation

By Application

·         Chronic Pain Management

·         Failed Back Syndrome

·         Epilepsy

·         Tremor

·         Incontinence

·         Depression

·         Dystonia

·         Gastroparesis

·         Parkinson’s Disease

·         Obsessive-Compulsive Disorder

·         Migraine

By End User

·         Hospitals

·         Clinics

·         Home Healthcare

By Country

·         US

·         Canada

·         Mexico

Company Profiles

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Neuromodulation Market – By Technology

1.3.2        Neuromodulation Market – By Application

1.3.3        Neuromodulation Market – By End User

1.3.4        North America Neuromodulation Market – By Country

2.             Neuromodulation Market – Key Takeaways

2.1       Coverage

2.2       Secondary Research

2.3       Primary Research

3.             North America Neuromodulation– Market Landscape

3.1       Overview

3.2       PEST Analysis

3.2.1        Expert Opinions

4.             Neuromodulation Market – Key Market Dynamics

4.1       Market Drivers

4.1.1        Increasing Incidence of Neurological Disorders

4.1.2        Growing Developments in Neuromodulation Technology

4.2       Market Restraints

4.2.1        High Cost of Neuromodulation Devices

4.3       Market Opportunities

4.3.1        Rising Demand for Neurostimulation Devices to Treat Chronic Pain

4.4       Future Trends

4.4.1        Technological Advancements

4.5       Impact Analysis

5.             Neuromodulation Market Analysis – By Technology

5.1       Overview

5.2       Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

5.3       External Neuromodulation

5.3.1        Overview

5.3.2        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.3.3        Respiratory Electrical Stimulation (RES)

5.3.3.1      Overview

5.3.3.2      Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.3.4        Transcutaneous Electrical Nerve Stimulation (TENS)

5.3.4.1      Overview

5.3.4.2      Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.3.5        Transcranial Magnetic Stimulation (TMS)

5.3.5.1      Overview

5.3.5.2      Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4       Internal Neuromodulation

5.4.1        Overview

5.4.2        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.3        Deep Brain Stimulation (DBS)

5.4.3.1      Overview

5.4.3.2      Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.4        Sacral Nerve Stimulation (DBS)

5.4.4.1      Overview

5.4.4.2      Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.5        Gastric Electric Stimulation (GES)

5.4.5.1      Overview

5.4.5.2      Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.6        Spinal Cord Stimulation (SCS)

5.4.6.1      Overview

5.4.6.2      Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

5.4.7        Vagus Nerve Stimulation (VNS)

5.4.7.1      Overview

5.4.7.2      Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.             Neuromodulation Market Analysis – By Application

6.1       Overview

6.2       Neuromodulation Market Share, by Application, 2019 and 2027 (%)

6.3       Chronic Pain Management

6.3.1        Overview

6.3.2        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4       Failed Back Syndrome

6.4.1        Overview

6.4.2        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.5       Epilepsy

6.5.1        Overview

6.5.2        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.6       Tremor

6.6.1        Overview

6.6.2        Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.7       Incontinence

6.7.1        Overview

6.7.2        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.8       Depression

6.8.1        Overview

6.8.2        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.9       Dystonia

6.9.1        Overview

6.9.2        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.10    Gastroparesis

6.10.1     Overview

6.10.2     Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.11    Parkinson’s Disease

6.11.1     Overview

6.11.2     Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.12    Obsessive-Compulsive Disorder (OCD)

6.12.1     Overview

6.12.2     Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

6.13    Migraine

6.13.1     Overview

6.13.2     Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.             Neuromodulation Market Analysis – By End User

7.1       Overview

7.2       Neuromodulation Market Share, by End User, 2019 and 2027, (%)

7.3       Hospitals

7.3.1        Overview

7.3.2        Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Clinics

7.4.1        Overview

7.4.2        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Home Healthcare

7.5.1        Overview

7.5.2        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.             Neuromodulation Market Analysis and Forecasts To 2027 – Regional Analysis

8.1       North America: Neuromodulation Market

8.1.1        Overview

8.1.2        North America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

8.1.3        North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.3.1      North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

8.1.3.2      North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.4        North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.5        North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.1.6        North America: Neuromodulation Market, by Country, 2019 & 2027 (%)

8.1.7        US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1      US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2      US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.7.2.1       US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.7.2.2       US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.7.3      US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.7.4      US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.1.8        Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1      Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2      Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.8.2.1       Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

8.1.8.2.2       Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.8.3      Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.8.4      Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

8.1.9        Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.1      Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.2      Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

8.1.9.2.1       Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

8.1.9.2.2       Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

8.1.9.3      Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.1.9.4      Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Impact of COVID-19 Pandemic on North America Neuromodulation Market

8.2       North America: Impact Assessment of COVID-19 Pandemic

9.             Company Profiles

9.1       Abbott

9.1.1        Key Facts

9.1.2        Business Description

9.1.3        Products and Services

9.1.4        Financial Overview

9.1.5        SWOT Analysis

9.1.6        Key Developments

9.2       Boston Scientific Corporation

9.2.1        Key Facts

9.2.2        Business Description

9.2.3        Products and Services

9.2.4        Financial Overview

9.2.5        SWOT Analysis

9.2.6        Key Developments

9.3       Medtronic

9.3.1        Key Facts

9.3.2        Business Description

9.3.3        Products and Services

9.3.4        Financial Overview

9.3.5        SWOT Analysis

9.3.6        Key Developments

9.4       NeuroPace, Inc.

9.4.1        Key Facts

9.4.2        Business Description

9.4.3        Products and Services

9.4.4        Financial Overview

9.4.5        SWOT Analysis

9.4.6        Key Developments

9.5       NeuroSigma, Inc.

9.5.1        Key Facts

9.5.2        Business Description

9.5.3        Products and Services

9.5.4        Financial Overview

9.5.5        SWOT Analysis

9.5.6        Key Developments

9.6       Nevro Corp.

9.6.1        Key Facts

9.6.2        Business Description

9.6.3        Products and Services

9.6.4        Financial Overview

9.6.5        SWOT Analysis

9.6.6        Key Developments

9.7       Synapse Biomedical Inc.

9.7.1        Key Facts

9.7.2        Business Description

9.7.3        Products and Services

9.7.4        Financial Overview

9.7.5        SWOT Analysis

9.7.6        Key Developments

9.8       Soterix Medical Inc

9.8.1        Key Facts

9.8.2        Business Description

9.8.3        Products and Services

9.8.4        Financial Overview

9.8.5        SWOT Analysis

9.8.6        Key Developments

9.9       Integer Holdings Corporation

9.9.1        Key Facts

9.9.2        Business Description

9.9.3        Products and Services

9.9.4        Financial Overview

9.9.5        SWOT Analysis

9.9.6        Key Developments

9.10    Magstim

9.10.1     Key Facts

9.10.2     Business Description

9.10.3     Products and Services

9.10.4     Financial Overview

9.10.5     SWOT Analysis

9.10.6     Key Developments

10.          Appendix

10.1    Glossary of Terms

LIST OF TABLES

Table 1.             North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 13.          Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 18.          Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Glossary of Terms, Neuromodulation Market

 

LIST OF FIGURES

Figure 1.           Neuromodulation Market Segmentation

Figure 2.           Neuromodulation Market – By Geography

Figure 3.           North America Neuromodulation Market Overview

Figure 4.           Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America Neuromodulation Market- Leading Country Markets (US$ Million)

Figure 7.           Research Methodology

Figure 8.           North America PEST Analysis

Figure 9.           Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 10.        Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 11.        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027  (US$ Million)

Figure 15.        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 22.        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 34.        Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        North America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 38.        North America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 39.        North America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 40.        US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Impact of COVID-19 Pandemic in North American Country Markets

 

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  1. Magstim
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the North Americanneuromodulationmarket

 

  • Highlights key business priorities to assist companies in order to realign their business strategies

 

  • Highlightskey findings and recommendations of crucial progressive industry trends in the North Americanneuromodulationmarket, thereby allowing players across the value chain to develop effective long-term strategies

 

  • Develops/modifiesbusiness expansion plans by using substantial growth offering developed and emerging markets

 

  • Scrutinizes in-depth North American market trends and outlook coupled with the factors driving the market, as well as those hindering it

 

  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription